
Am J Psychiatry 161:1776-1782, October 2004
© 2004 American Psychiatric Association
Altered NMDA Glutamate Receptor Antagonist Response in Individuals With a Family Vulnerability to Alcoholism
Ismene L. Petrakis, M.D.,
Diana Limoncelli, B.A.,
Ralitza Gueorguieva, Ph.D.,
Peter Jatlow, M.D.,
Nashaat N. Boutros, M.D.,
Louis Trevisan, M.D.,
Joel Gelernter, M.D., and
John H. Krystal, M.D.
OBJECTIVE: A family history of alcoholism is a risk factor for the development of ethanol dependence. Ethanol is an antagonist of the N-methyl-D-aspartate (NMDA) glutamate receptor, and alterations in NMDA receptor function are thought to be involved in ethanol abuse and dependence. The purpose of this study was to determine in healthy individuals with no ethanol dependence whether response to the NMDA receptor antagonist ketamine would differentiate those with a family history of ethanol dependence from those without such a family history. METHOD: Healthy subjects between the ages of 21 and 30 received 40-minute intravenous infusions of saline, low-dose ketamine (0.1 mg/kg), and high-dose ketamine (0.5 mg/kg) on three separate test days in a randomized order under double-blind conditions. The healthy individuals with at least one first-degree relative and another first- or second-degree relative with ethanol dependence (N=16) were compared with those who had no family history of ethanol dependence in any first- or second-degree relative (N=29). Outcome measures included the Brief Psychiatric Rating Scale, Clinician-Administered Dissociative States Scale, verbal fluency, Hopkins Verbal Learning Test, a biphasic alcohol effects scale, visual analog scales of mood states, and ketamine levels. RESULTS: During ketamine infusion, individuals with a family history of ethanol dependence showed an attenuated response in terms of perceptual alterations and dysphoric mood relative to those without such a family history. CONCLUSIONS: These data suggest that alterations in NMDA receptor function may contribute to subjective response to ethanol and therefore also to the risk of developing alcoholism.
This article has been cited by other articles:

|
 |

|
 |
 
R. Machado-Vieira, H. K. Manji, and C. A. Zarate
The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders
Neuroscientist,
October 1, 2009;
15(5):
525 - 539.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Schumann, M. Johann, J. Frank, U. Preuss, N. Dahmen, M. Laucht, M. Rietschel, D. Rujescu, A. Lourdusamy, T.-K. Clarke, et al.
Systematic Analysis of Glutamatergic Neurotransmission Genes in Alcohol Dependence and Adolescent Risky Drinking Behavior
Arch Gen Psychiatry,
July 1, 2008;
65(7):
826 - 838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-C. Lai, T.-I. Kuo, and H.-H. Lin
The Role of Protein Kinase A in Acute Ethanol-Induced Neurobehavioral Actions in Rats
Anesth. Analg.,
July 1, 2007;
105(1):
89 - 96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Pomarol-Clotet, G. D. Honey, G. K. Murray, P. R. Corlett, A. R. Absalom, M. Lee, P. J. McKenna, E. T. Bullmore, and P. C. Fletcher
Psychological effects of ketamine in healthy volunteers: Phenomenological study
The British Journal of Psychiatry,
August 1, 2006;
189(2):
173 - 179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Arehart-Treichel
Brain-Receptor Abnormality Linked to Alcoholism Risk
Psychiatr News,
November 5, 2004;
39(21):
39 - 42.
[Full Text]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2004
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|